Titre : | Treatment compliance in patients with comorbid psychiatric and substance use disorders |
Titre traduit : | (Observance du traitement chez les patients présentant des problèmes d'usage de substances et de troubles psychiatriques comorbides) |
Auteurs : | D. M. HERBECK ; D. J. FITEK ; D. S. SVIKIS ; I. D. MONTOYA ; S. C. MARCUS ; J. C. WEST |
Type de document : | Périodique |
Année de publication : | 2005 |
Format : | 195-207 / tabl. |
Note générale : |
American Journal on Addictions, 2005, 14, (3), 195-207 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés OBSERVANCE DU TRAITEMENT ; COMORBIDITE ; PSYCHIATRIE ; TROUBLES DE LA PERSONNALITE ; FACTEUR DE VULNERABILITE ; EPIDEMIOLOGIE DESCRIPTIVE |
Résumé : |
ENGLISH : This study examines clinical and non-clinical factors associated with treatment compliance problems in 342 patients with substance use disorders (SUD) seen in routine psychiatric practice. Weighted Wald-X2 and multivariate logistic regression assessed sociodemographic, clinical, treatment, and health plan characteristics associated with treatment compliance problems. Among patients with SUD, 40.5% were reported to currently have treatment compliance problems. Patients with treatment compliance problems were significantly more likely to have personality disorders, lower global assessment of functioning scores, and medication side effects than those without treatment compliance problems. Patients seen by psychiatrists who were reimbursed by discounted rather than undiscounted fee-for-service were five times more likely to be reported to have treatment compliance problems. Both clinical and non-clinical factors appear to be associated with treatment compliance problems. Understanding these factors and targeting treatment interventions may improve treatment compliance and patient outcomes. (Review' s abstract) |
Note de contenu : | tabl. |
Domaine : | Plusieurs produits / Several products |
Refs biblio. : | 33 |
Affiliation : |
UCLA Integrated Substance Abuse Programs, 1640 S. Sepulveda blvd, Suite 200, Los Angeles, CA 90025 ; mail : dherbeckucla.edu Etats-Unis. United States. |
Numéro Toxibase : | 208257 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil